
    
      The investigators refer to the trial with clinicaltrials.gov indentifier NCT02610933 entitled
      Effect on Vascular Calcification of Replacing Warfarin by Rivaroxaban With or Without VitK2
      in Hemodialysis Patients.

      After termination of this trial, included patients will be asked to participate in the
      extension trial by continuing the treament of their respective allocation arm. No new
      intervention will be done. Relevant endpoints like death, cardiovascular events and bleeding
      episodes will be registered.
    
  